Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: Randomized controlled trial

Photodermatology Photoimmunology and Photomedicine

Volumn 29, Issue 4, 2013, Pages 173-181

  Buinauskaite, Evelina ^a   Zalinkevicius, Rimantas ^a   Buinauskiene, Jurate ^a   Valiukeviciene, Skaidra ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

5 aminolevulinic acid; Actinic keratosis; Pain; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID;

ACTINIC KERATOSIS; AGED; APPLICATION SITE PAIN; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE; FOLLOW UP; HUMAN; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RED LIGHT; TOPICAL TREATMENT; VISUAL ANALOG SCALE;

5-AMINOLEVULINIC ACID; ACTINIC KERATOSIS; PAIN; PHOTODYNAMIC THERAPY;

AGED; AMINOLEVULINIC ACID; ANIMALS; FACE; FEMALE; HUMANS; MALE; PAIN; PAIN MEASUREMENT; PHOTOCHEMOTHERAPY; PHOTOSENSITIVITY DISORDERS; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; SCALP;

EID: 84879823581     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/phpp.12044     Document Type: Article

References (34)

1. Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol 2000; 42 (1 Pt 2): 23-24.
2. Leffell DJ. The scientific basis of skin cancer. J Am Acad Dermatol 2000; 42 (1 Pt 2): 18-22.
3. Lang K, Lehmann P, Bolsen K etal. Aminolevulinic acid: pharmacological profile and clinical indication. Expert Opin Investig Drugs 2001; 10: 1139-1156.
4. Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42 (1 Pt 2): 4-7.
5. Lehmann P. Side effects of topical photodynamic therapy. Hautarzt 2007; 58: 597-603.
6. Arits AHMM, van de Weert MM, Nelemans PJ, Kelleners-Smeets NW. Pain during topical photodynamic therapy: uncomfortable and unpredictable. J Eur Acad Dermatol Venereol 2010; 24: 1452-1457.
7. Grapengiesser S, Ericson M, Gudmundsson F etal. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 2002; 27: 493-497.
8. Wennberg AM. Pain, pain relief and other practical issues in photodynamic therapy. Australas J Dermatol 2005; 46 (Suppl): S3-S4.
9. Olsen EA, Abernethy ML, Kulp-Shorten C etal. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 1991; 24: 738-743.
10. Fitzpatrick TB. The validity and practicality of sun reactive skin types I through VI. Arch Dermatol 1988; 124: 869-871.
11. Cockerell CJ. New histopathological classification of actinic keratosis. J Drugs Dermatol 2005; 4: 462-467.
12. Babilas P, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology. Eur J Dermatol 2006; 16: 340-348.
13. Langan SM, Collins P. Randomized, double-blind, placebo controlled prospective study of the efficacy of topical anaesthesia with a eutectic mixture of lignocaine 2.5% and prilocaine 2.5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic keratoses. Br J Dermatol 2006; 154: 146-149.
14. Sandberg C, Stenquist B, Rosdahl I etal. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol 2006; 86: 404-408.
15. Halldin CB, Gillstedt M, Paoli J etal. Predictors of pain associated with photodynamic therapy: a retrospective study of 658 treatments. Acta Derm Venereol 2011; 91: 545-551.
16. Kasche A, Luderschmidt S, Ring J, Hein R. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol 2006; 5: 353-356.
17. Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol 2003; 139: 1313-1320.
18. Waters AJ, Ibbotson SH. Parameters associated with severe pain during photodynamic therapy: results of a large Scottish series. Br J Dermatol 2011; 165: 696-698.
19. Attili SK, Dawe R, Ibbotson S. A review of pain experienced during topical photodynamic therapy - our experience in Dundee. Photodiagnosis Photodyn Ther 2011; 8: 53-57.
20. Gholam P, Denk K, Sehr T etal. Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses. J Am Acad Dermatol 2010; 63: 213-218.
21. Virgili A, Osti F, Maranini C, Corazza M. Photodynamic therapy: parameters predictive of pain. Br J Dermatol 2010; 162: 460-461.
22. Steinbauer JM, Schreml S, Babilas P etal. Topical photodynamic therapy with porphyrin precursors - assessment of treatment-associated pain in a retrospective study. Photochem Photobiol Sci 2009; 8: 1111-1116.
23. Agostino R, Cruccu G, Iannetti G etal. Topographical distribution of pinprick and warmth thresholds to CO2 laser stimulation on the human skin. Neurosci Lett 2000; 285: 115-118.
24. Wiegell SR, Skiveren J, Philipsen PA, Wulf HC. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol 2008; 158: 727-733.
25. Gaál M, Otrosinka S, Baltás E etal. Photodynamic therapy of non-melanoma skin cancer with methyl aminolaevulinate is associated with less pain than with aminolaevulinic acid. Acta Derm Venereol 2012; 92: 173-175.
26. Lindeburg KE, Brogaard HM, Jemec GB. Pain and photodynamic therapy. Dermatology 2007; 215: 206-208.
27. Mikolajewska P, Iani V, Juzeniene A, Moan J. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema. Br J Dermatol 2009; 161: 1173-1179.
28. Moloney FJ, Collins P. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Br J Dermatol 2007; 157: 87-91.
29. Ericson MB, Sandberg C, Stenquist B etal. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol 2004; 151: 1204-1212.
30. Clark C, Bryden A, Dawe R etal. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 2003; 19: 134-141.
31. Apalla Z, Sotiriou E, Panagiotidou D etal. The impact of different fluence rates on pain and clinical outcome in patients with actinic keratoses treated with photodynamic therapy. Photodermatol Photoimmunol Photomed 2011; 27: 181-185.
32. Ibbotson SH. Irradiance is an important determinant of pain experienced during topical photodynamic therapy. J Am Acad Dermatol 2011; 65: 201-202.
33. Babilas P, Kohl E, Maisch T etal. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol 2006; 154: 712-718.
34. Radakovic-Fijan S, Blecha-Thalhammer U, Kittler H etal. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study. J Am Acad Dermatol 2005; 53: 823-827.